NR4A2 and Parkinson disease: Polymorphisms in genes such as LRRK2, S100B (S100 calcium-binding protein B), and NURR1 (nuclear receptor subfamily 4 group A member 2), along with neuroinflammation, were discovered to significantly elevate the risk for developing PD.